The metastatic triple-negative breast cancer (mTNBC) market is estimated to be valued at USD 1.57 Bn in 2024 and is expected to reach USD 2.2 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5% from 2024 to 2031. https://articlescad.com/mtnbc-market-is-trending-by-increased-cancer-research-and-development-52658.html